Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.

OBJECTIVE We sought to determine the critical diameter of a peripheral non-small cell lung cancer tumor less than which no evidence of nodal micrometastasis is present. METHODS Samples of 3081 lymph nodes from 181 patients with stage I peripheral lung cancer (155 with adenocarcinoma and 26 with squamous cell carcinoma) who had undergone complete resection with systematic lymphadenectomy were used in the study. In the samples immunohistochemical staining for cytokeratin was performed. The expression of vascular endothelial growth factor (VEGF) at primary sites was also immunohistochemically assessed. RESULTS Nodal micrometastasis was detected in 44 patients. The mean tumor sizes were 2.2 +/- 1.3 cm (range, 1.0-7.0 cm) in nodal micrometastasis-positive adenocarcinoma, 2.1 +/- 0.9 cm (range, 0.5-6.0 cm) in nodal micrometastasis-negative adenocarcinoma, 4.8 +/- 2.3 cm (range, 2.2-10.0 cm) in nodal micrometastasis-positive squamous cell carcinoma, and 3.2 +/- 2.1 cm (range, 0-9.0 cm) in nodal micrometastasis-negative squamous cell carcinoma. The tumor size in the nodal micrometastasis-positive group tended to be greater than that in the nodal micrometastasis-negative group in squamous cell carcinomas, but there was no significant difference in adenocarcinomas. Nodal micrometastasis was not found in patients with squamous cell carcinoma of 2.0 cm or less in diameter. However, nodal micrometastasis was found in 20% (19/95) of the patients with adenocarcinoma of 1.1 to 2.0 cm in diameter and even in 4 of 11 patients with adenocarcinoma of 1.0 cm or less. Among the patients with nodal micrometastasis, survival of patients with vascular endothelial growth factor overexpression was worse than that of patients without it. The survival of patients with nodal micrometastasis without vascular endothelial growth factor overexpression was comparable with that of patients without nodal micrometastasis. CONCLUSION A limited surgical intervention without lymphadenectomy is validated for squamous cell carcinoma of 2.0 cm or less without pleural involvement. In adenocarcinoma the tumor size itself is not a reliable guide for nodal micrometastasis status. In patients with nodal micrometastasis with vascular endothelial growth factor overexpression, the risk of systemic disease should be considered.

[1]  M. Okada,et al.  Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? , 2001, The Annals of thoracic surgery.

[2]  M. Oda,et al.  Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. , 1999, The Annals of thoracic surgery.

[3]  H. Kato,et al.  Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. , 1998, Lung cancer.

[4]  J. Izbicki,et al.  Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. , 1996, The Journal of thoracic and cardiovascular surgery.

[5]  G. Watanabe,et al.  Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. , 2001, The Annals of thoracic surgery.

[6]  S. Adak,et al.  Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer , 2000 .

[7]  R. Tsuchiya,et al.  Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? , 1996, The Journal of thoracic and cardiovascular surgery.

[8]  N. Ishikawa,et al.  Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. , 1998, Lung cancer.

[9]  A. Nicholson,et al.  Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas? , 1997, Lung cancer.

[10]  K. Sugimachi,et al.  Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.

[11]  M. Oda,et al.  Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. , 2000, The Journal of thoracic and cardiovascular surgery.

[12]  K. Haeussinger,et al.  Radical systematic mediastinal lymphadenectomy in non‐small cell lung cancer: A randomized controlled trial , 1994, The British journal of surgery.

[13]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[14]  J. Segall,et al.  Imaging of cancer invasion and metastasis using green fluorescent protein. , 2000, European journal of cancer.

[15]  R. Tsuchiya,et al.  The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. , 1988, The Annals of thoracic surgery.

[16]  R. Read,et al.  Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. , 1990, The Annals of thoracic surgery.

[17]  Setsuo Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .

[18]  N. Tsubota,et al.  Ongoing prospective study of segmentectomy for small lung tumors. Study Group of Extended Segmentectomy for Small Lung Tumor. , 1998, The Annals of thoracic surgery.

[19]  M. Oda,et al.  Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  R. Hutter,et al.  Significance of Axillary Macrometastases and Micrometastases in Mammary Cancer , 1971, Annals of surgery.

[21]  M. Higashiyama,et al.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. , 1997, The Journal of thoracic and cardiovascular surgery.

[22]  A. Cochran,et al.  Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. , 1993, Journal of the National Cancer Institute.

[23]  W. Warren,et al.  Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. , 1994, The Journal of thoracic and cardiovascular surgery.

[24]  J. Izbicki,et al.  Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. , 1998, Annals of surgery.

[25]  N. Martini,et al.  Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. , 1983, Annals of surgery.

[26]  K. Esato,et al.  Systematic Lymph Node Dissection for Clinically Diagnosed Peripheral Non-Small-Cell Lung Cancer Less Than 2 cm in Diameter , 1998, World Journal of Surgery.